Intraosseous Local Anesthesia System in Children With Molar Incisor Hypomineralization
Launched by ISTANBUL UNIVERSITY · Jun 11, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how well two different methods of numbing the mouth work for children with a condition called molar incisor hypomineralization (MIH). MIH can make teeth sensitive and more prone to decay. The researchers want to find out if a technique called intraosseous anesthesia, which injects numbing medicine directly into the bone around the tooth, is more effective at controlling pain during dental work compared to the more commonly used inferior alveolar block anesthesia.
To participate, children aged 6 to 8 who are healthy and have at least one affected lower first molar may be eligible. They should have a specific level of dental need and be able to cooperate during treatment. This trial is currently recruiting participants at the Department of Pedodontics at Istanbul University Faculty of Dentistry. If your child qualifies and joins the study, they can expect to receive one of the two types of anesthesia during their dental treatment, and their pain levels will be monitored to see which method works better.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Individuals applying the Department of Pedodontics, Istanbul University Faculty of Dentistry,
- • Systemically healthy,
- • Without any allergies,
- • Having at least one mandibular first molar with molar incisor hypomineralization (MIH),
- • Treatment need index 2 and 4,
- • Having a radiographically advanced decay lesion involving dentin (outer ½),
- • Possessing sufficient cooperation skills (Frankl scale 3 and 4),
- • Between the ages of 6-8,
- • Both male and female volunteers will be included.
- Exclusion Criteria:
- • -
About Istanbul University
Istanbul University, a leading institution in Turkey, is dedicated to advancing healthcare through rigorous clinical research and education. Renowned for its commitment to scientific excellence and innovation, the university sponsors clinical trials that aim to enhance medical knowledge and improve patient outcomes. With a diverse team of researchers and healthcare professionals, Istanbul University fosters collaboration across disciplines to explore new therapeutic interventions and contribute to global health advancements. Its robust infrastructure and ethical standards ensure the highest quality in clinical trial management, making it a key player in the field of medical research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Istanbul, , Turkey
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported